期刊文献+

靶向阻断转化生长因子-β信号通路对肿瘤特异性细胞毒性T淋巴细胞的影响 被引量:3

Effect of blocking the transforming growth factor-beta signaling pathway on tumor-specific cytotoxic T lymphocytes
在线阅读 下载PDF
导出
摘要 目的细胞毒性T淋巴细胞(cytotoxic T lymphocyte,CTL)是体内杀伤肿瘤的最终效应细胞,但其免疫功能会被肿瘤分泌的转化生长因子β(transforming growth factorβ,TGF-β)所抑制,文中观察靶向阻断TGF-β信号通路对肿瘤特异性CTL的影响。方法利用包涵修饰过的TGF-βⅡ型受体(transforming growth factorβreceptor typeⅡ,TβRⅡ)质粒的逆转录病毒载体,转染经DC激活的小鼠肾癌Renca细胞敏感的CTL(tumor pulsed CTL,TP-CTL),获得对TGF-β不敏感而肿瘤特异性的CTL(TβRⅡDN-CTL),Western blot检测Smad-2的磷酸化情况,观察TGF-β对CTL体外增殖抑制情况,将TβRⅡDN-CTL与未阻断TGF-β信号通路TP-CTL分别与相关及无关肿瘤细胞共同孵育,应用51Cr释放实验测定其细胞毒作用,将已成瘤的动物模型分为TP-CTL组和TβRⅡDN-CTL组分别尾静脉过继性注射TP-CTL及TβRⅡDN-CTL,ELISA法检测小鼠体内IL-2和IFN-γ水平。结果 TβRⅡDN-CTL组对TGF-β增殖抑制率明显低于TP-CTL组(65.96%vs 2.08%,P<0.01);在效靶比为100∶1时,TβRⅡDN-CTL组较TP-CTL组显著提高免疫小鼠CTL的特异性杀伤作用[(50.40±4.48)%vs(17.70±1.42)%,P<0.01],而动物模型血浆中TβRⅡDN-CTL组较TP-CTL组的IL-2、IFN-γ水平也显著升高(P<0.01)。结论阻断肿瘤敏感的CTL的TGF-β信号通路可以克服肿瘤的免疫抑制作用,提高CTL对肿瘤的杀伤效率。 Objective Cytotoxic T lymphocytes ( CTLs) are final effect tumor-killer cells in the body and their immune func-tion can be suppressed by the transforming growth factor-beta ( TGF-β) secreted from the tumor .We observed the effect of blocking the TGF-βsignaling pathway on tumor-specific CTLs. Methods Tumor lysate-pulsed CTLs (TP-CTLs) were activated to be sensitive to mouse renal cancer cells with dendritic cells and transfected with a retrovirus containing dominant -negative TGF-βtype Ⅱ receptor ( TβRⅡDN) for isolation of TGF-β-insensitive tumor-specific TβRⅡDN-CTLs.Western blot was used to measure the level of phos-phorylated Smad-2 and evaluate the inhibitory effect of TGF-βon the proliferation of CTLs .The cytotoxic effect of TGF-βwas detected by 51 Cr releasing test , and the levels of serum IL-2 and INF-γin the mouse model determined by ELISA . Results TGF-βshowed a significantly lower rate of inhibition on the proliferation of the TβRⅡDN-CTLs than on that of the TP-CTLs (2.08%vs 65.96%, P〈0.01).In the effect-target ratio of 100∶1, the cytotoxic effect of TGF-βon the TβRⅡDN-CTLs was markedly higher than that on the TP-CTLs ([50.4 ±4.48]%vs [17.7 ±1.42]%, P〈0.01), and so were the levels of serum IL-2 ([1541.05 ±36.75] pg/mL vs
出处 《医学研究生学报》 CAS 北大核心 2015年第3期240-244,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(81472392 81372741) 南京军区南京总医院科研基金(2013030)
关键词 转化生长因子Β 细胞毒性T淋巴细胞 免疫治疗 肾癌 Transforming growth factor beta Cytotoxic T lymphocyte Immunotherapy Renal carcinoma
  • 相关文献

参考文献15

  • 1Pickup M,Novitskiy S,Moses HL.The roles of TGF-β in the tumour microenvironment[J].Nat Rev Cancer,2013,13(11): 788-799.
  • 2Oh SA,Li MO.TGF-β: guardian of T cell function[J].J Immunol,2013,191(8): 3973-3979.
  • 3Kalos M,June CH.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology[J].Immunity,2013,39(1): 49-60.
  • 4Rosenberg SA,Dudley ME.Adoptive cell therapy for the treatment of patients with metastatic melanoma[J].Curr Opin Immunol,2009,21(2): 233-240.
  • 5Junker N,Andersen MH,Wenandy L,et al.Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer[J].Cytotherapy,2011,13(7): 822-834.
  • 6Polak ME,Borthwick NJ,Jager MJ,et al.Melanoma vaccines: The problems of local immunosuppression[J].Hum Immunol,2009,70(5): 331-339.
  • 7董杰,王龙信,唐朝朋,邢潇潇,张征宇,葛京平,秦卫军,田丰.转化生长因子β不敏感的树突状细胞疫苗对肾细胞癌荷瘤小鼠细胞毒性T淋巴细胞的影响[J].医学研究生学报,2013,26(5):455-459. 被引量:8
  • 8Payne KK,Toor AA,Wang XY,et al.Immunotherapy of cancer: reprogramming tumor-immune crosstalk[J].Clin Dev Immunol,2012,2012: 760965.
  • 9Kaufman HL.Vaccines for melanoma and renal cell carcinoma[J].Semin Oncol,2012,39(3): 263-275.
  • 10Kudo-Saito C,Shirako H,Ohike M,et al.CCL2 is critical for immunosuppression to promote cancer metastasis[J].Clin Exp Metastasis,2013,30(4): 393-405.

二级参考文献20

共引文献10

同被引文献6

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部